Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
107.40    0.00 (0.00%)
Bid:
82.00
Ask:
0.00
Spread: 25.40 (30.976%)
Market Cap: £176.08m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

FRS 101 Notification

10 Feb 2016 07:00

RNS Number : 4117O
Synthomer PLC
10 February 2016
 

NOTIFICATION TO SHAREHOLDERS IN ACCORDANCE WITH FRS 101

Synthomer plc has today posted a letter to shareholders, the full text of which is set out below.

 

 

Dear Shareholder

 

NOTIFICATION TO SHAREHOLDERS IN ACCORDANCE WITH FRS 101

 

On 1 January 2015 a new UK GAAP reporting regime became effective and, as a result, Synthomer plc ("the Company"), the parent company of the Synthomer Group, is obliged to transition to a replacement accounting framework for its financial statements for the financial year ended 31 December 2015. Accordingly, consistent with UK listed company market practice, your Board has decided to adopt FRS 101 "Reduced Disclosure Framework" for its Company financial statements. In this connection it is possible to elect to take advantage of disclosure exemptions, however, the Company disclosures are expected to be the same as, or follow closely, those reported under previous UK GAAP. There is no change to the accounting framework for the Group's consolidated financial statements, which will continue to be prepared in accordance with International Financial Reporting Standards, as adopted in the European Union.

 

Whilst your Board's decision does not require shareholder approval we are required under the rules issued by the Financial Reporting Council to inform our shareholders about the adoption of FRS 101, and to provide a reasonable opportunity for our shareholders to object. You do not need to reply to this letter, but any shareholder or shareholders holding in aggregate 5% or more of the total allotted shares in Synthomer plc can object to the adoption of FRS 101, if they wish to do so, by writing to the Company Secretary at Synthomer plc, Central Road, Harlow, Essex, CM20 2BH before 26 February 2016.

 

The election will apply on an ongoing basis until such time as the Company notifies shareholders of any change to its chosen accounting framework for its financial statements.

 

Contact: Richard Atkinson, Company Secretary

Stephen Bennett, Chief Financial Officer

UK Switchboard: +44 (0)1279 436 211

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSSFFLAFMSEIE
Date   Source Headline
30th Jul 201912:54 pmRNSDirector/PDMR Shareholding
30th Jul 201912:53 pmRNSDirector/PDMR Shareholding
30th Jul 201912:52 pmRNSDirector/PDMR Shareholding
30th Jul 201912:51 pmRNSDirector/PDMR Shareholding
30th Jul 201912:50 pmRNSDirector/PDMR Shareholding
30th Jul 201912:48 pmRNSDirector/PDMR Shareholding
30th Jul 201912:48 pmRNSDirector/PDMR Shareholding
30th Jul 201911:31 amRNSResults of Rump Placing
30th Jul 20197:00 amRNSResults of Rights Issue
26th Jul 20192:48 pmRNSDirector/PDMR Shareholding
26th Jul 20192:46 pmRNSDirector/PDMR Shareholding
24th Jul 20194:34 pmRNSDirector Declaration
15th Jul 20197:00 amRNSAdmission of Nil Paid Rights
10th Jul 20191:49 pmRNSPublication of Circular and Prospectus
10th Jul 20191:34 pmRNSDirector/PDMR Shareholding
3rd Jul 20197:00 amRNSAcquisition
2nd Jul 20193:56 pmRNSDirector Declaration
13th Jun 201911:18 amRNSDirector Declaration
25th Apr 20194:45 pmRNSResult of AGM
25th Apr 20197:00 amRNSQ1 Trading Update
10th Apr 20194:51 pmRNSDirector/PDMR Shareholding
10th Apr 20194:50 pmRNSDirector/PDMR Shareholding
10th Apr 20194:43 pmRNSDirector/PDMR Shareholding
10th Apr 20194:41 pmRNSDirector/PDMR Shareholding
28th Mar 20193:51 pmRNSDirector/PDMR Shareholding
28th Mar 20193:50 pmRNSDirector/PDMR Shareholding
25th Mar 20193:15 pmRNSAnnual Financial Report
21st Mar 20193:39 pmRNSDirector Declaration
18th Mar 201910:02 amRNSDirector/PDMR Shareholding
12th Mar 201911:25 amRNSDirector/PDMR Shareholding
12th Mar 201911:23 amRNSDirector/PDMR Shareholding
5th Mar 20194:09 pmRNSDirector/PDMR Shareholding
4th Mar 20197:00 amRNSResults for the year ended 31 December 2018
1st Mar 20193:26 pmRNSDirector Declaration
3rd Dec 201810:54 amRNSHolding(s) in Company
9th Nov 201811:36 amRNSDirector/PDMR Shareholding
6th Nov 20187:00 amRNSQ3 Trading update
17th Oct 20189:29 amRNSDirector Declaration
21st Sep 20189:17 amRNSDirectorate Change
6th Aug 20187:00 amRNSResults for the six months ended 30 June 2018
11th Jul 20186:25 pmRNSDirector/PDMR Shareholding
10th Jul 20189:47 amRNSHolding(s) in Company
4th Jul 201811:45 amRNSHolding(s) in Company
4th Jul 201811:44 amRNSHolding(s) in Company
4th Jul 201811:43 amRNSHolding(s) in Company
28th Jun 20183:12 pmRNSUpdate on Proposed Offering
25th Jun 20187:19 amRNSPROPOSED OFFERING OF EUR300M BOND & REFINANCING
21st Jun 201810:16 amRNSResult of Extraordinary General Meeting
8th Jun 20187:00 amRNSEuropean Commission investigation
4th Jun 20181:02 pmRNSNotice of GM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.